Previous Article | Next Article ![]()
Journal of Virology, May 2001, p. 4399-4401, Vol. 75, No. 9
Department of Virology, Faculty of Medicine,
Kyushu University, Fukuoka 812-8582,1
Department of Pediatrics, Kitakyushu Municipal Medical Center,
Kitakyushu 802-0077,2 and Fukuoka City
Children's Hospital and Medical Center for Infectious Disease,
Fukuoka 810-0063,3 Japan
Received 7 December 2000/Accepted 29 January 2001
Both CD46 and signaling lymphocytic activation molecule (SLAM) have
been shown to act as cellular receptors for measles virus (MV). The
viruses on throat swabs from nine patients with measles in Japan were
titrated on Vero cells stably expressing human SLAM. Samples from all
but two patients produced numerous plaques on SLAM-expressing Vero
cells, whereas none produced any plaques on Vero cells endogenously
expressing CD46. The Edmonston strain of MV, which can use either CD46
or SLAM as a receptor, produced comparable titers on these two types of
cells. The results strongly suggest that the viruses in the bodies of
measles patients use SLAM but probably not CD46 as a cellular receptor.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.9.4399-4401.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Measles Viruses on Throat Swabs from Measles
Patients Use Signaling Lymphocytic Activation Molecule (CDw150)
but Not CD46 as a Cellular Receptor
*
Corresponding author. Mailing address: Department of
Virology, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan. Phone: 81-92-642-6135. Fax: 81-92-642-6140. E-mail:
yyanagi{at}virology.med.kyushu-u.ac.jp.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|